2020 - 2023 Elucidation of the effect of Microorganism of the body on the origin and rupture of the intracranial aneurysms and development of preventive measure of the subarachnoid hemorrhage
2018 - 2022 Development of therapeutic herpes simple virus vector through comprehensive mutagenesis and gene expression profiling
2017 - 2019 オミックス解析を基盤とする遺伝子治療用ヘルペスウイルスベクターの合理的設計
Papers (128):
Shinju Iyoda, Kenichi Yoshida, Kota Shoji, Nana Ito, Miu Tanaka, Yasuhito Nannya, Genki Yamato, Shinichi Tsujimoto, Norio Shiba, Yasuhide Hayashi, et al. KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia. Leukemia. 2024. 38. 7. 1609-1612
Tomomi Nishimura, Nobuyuki Kakiuchi, Kenichi Yoshida, Takaki Sakurai, Tatsuki R Kataoka, Eiji Kondoh, Yoshitsugu Chigusa, Masahiko Kawai, Morio Sawada, Takuya Inoue, et al. Evolutionary histories of breast cancer and related clones. Nature. 2023. 620. 7974. 607-614
Tomomi Nishimura, Nobuyuki Kakiuchi, Kenichi Yoshida, Yasuhide Takeuchi, Hirona Maeda, Yusuke Shiozawa, Masahiro Hirata, Tatsuki R. Kataoka, Takaki Sakurai, Satoko Baba, et al. Clonal evolution of proliferative lesions into breast cancers. CANCER SCIENCE. 2021. 112. 157-157
Yotaro Ochi, Kenichi Yoshida, Ko Sasaki, Noriko Hosoya, Yusuke Shiozawa, Yasuhito Nannya, Takayuki Ishikawa, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, et al. Genetic profiling and prognosis of blast crisis in chronic myeloid leukemia. CANCER SCIENCE. 2021. 112. 454-454
June Takeda, Kenichi Yoshida, Akinori Yoda, Yasuhito Nannya, Masahiro Nakagawa, Yotaro Ochi, Ayana Kon, Tetsuichi Yoshizato, Yusuke Shiozawa, Yuichi Shiraishi, et al. JAK STAT Pathway is a Promising Therapeutic target in Acute Erythroid Leukemia. CANCER SCIENCE. 2021. 112. 453-453
Yasuhide Takeuchi, Hiromichi Suzuki, Kenichi Yoshida, Yuichi Shiraishi, Nobuyuki Kakiuchi, Yusuke Shiozawa, Yoshikage Inoue, Kenichi Chiba, Hideki Makishima, Satoru Miyano, et al. Frequent abnormalities in TP53 and increased genetic instability in myxofibrosarcoma. CANCER SCIENCE. 2021. 112. 850-850